A5009538383- Sarcoma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Tumors and Oncological Cases
- Neuroblastoma Research and Treatments
- Lymphoma Diagnosis and Treatment
- Surgical site infection prevention
- Hematopoietic Stem Cell Transplantation
- Radiation Therapy and Dosimetry
- Acute Lymphoblastic Leukemia research
- Management of metastatic bone disease
- Testicular diseases and treatments
- Vascular Tumors and Angiosarcomas
- Childhood Cancer Survivors' Quality of Life
- Brain Metastases and Treatment
- Cardiac tumors and thrombi
- Meningioma and schwannoma management
- Prostate Cancer Diagnosis and Treatment
- Bone Tumor Diagnosis and Treatments
- Neurofibromatosis and Schwannoma Cases
- Advances in Oncology and Radiotherapy
- Soft tissue tumor case studies
- Colorectal and Anal Carcinomas
- Hepatocellular Carcinoma Treatment and Prognosis
- Radiation Dose and Imaging
Istituto Oncologico Veneto
2016-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2015-2025
University of Padua
1997-2022
Associazione Italiana Ematologia Oncologia Pediatrica
2017
Fondazione IRCCS Istituto Nazionale dei Tumori
2016
Fondazione IRCCS Istituto Neurologico Carlo Besta
2016
Tel Aviv Sourasky Medical Center
2013
Université de Lorraine
2012
Azienda Ospedaliera di Padova
1999-2005
Santa Maria Nuova Hospital
2005
<h2>Abstract</h2><h3>Background</h3> The use of chemotherapy to manage newly diagnosed low grade glioma (LGG) was first introduced in the 1980s. One randomised trial has studied two- versus four-drug regimens with a duration 12 months treatment after resection. <h3>Methods</h3> Within European comprehensive strategy for childhood LGG, International Society Paediatric Oncology–Low Grade Glioma (SIOP LGG) Committee launched involving 118 institutions and 11 countries investigate addition...
This prospective study stratified patients by surgical resection (complete = NED vs incomplete ED) and centrally reviewed histology (World Health Organization [WHO] grade II III). WHO II/NED received focal radiotherapy (RT) up to 59.4 Gy with 1.8 Gy/day. Grade III/NED 4 courses of VEC (vincristine, etoposide, cyclophosphamide) after RT. ED 1–4 courses, second-look surgery, followed an 8-Gy boost in 2 fractions on still measurable residue. children aged 1–3 years tumors could receive 6 alone....
The objective of this study was to investigate the role clinical factors together with FOXO1 fusion status in patients nonmetastatic rhabdomyosarcoma (RMS) develop a predictive model for event-free survival and provide rationale risk stratification future trials.
The European Society for Paediatric Oncology (SIOPE) Radiation Working Group presents the QUARTET Project: a centralised quality assurance programme designed to standardise care and improve of radiotherapy imaging international clinical trials recruiting children adolescents with cancer throughout Europe. combines paediatric radiation oncology expertise SIOPE infrastructure experience Organisation Research Treatment Cancer deliver programmes large, prospective, trials. QUARTET-affiliated...
Myeloablative Total Body Irradiation (TBI) is an important modality in conditioning for allogeneic hematopoietic stem cell transplantation (HSCT), especially children with high-risk acute lymphoblastic leukemia (ALL). TBI practices are heterogeneous and institution-specific. Since associated multiple late adverse effects, recommendations may help to standardize improve the outcome versus toxicity ratio children. The European Society Paediatric Oncology (SIOPE) Radiotherapy Working Group...
Background and purpose The of this study was to address the lack published data on use brachytherapy in pediatric rhabdomyosarcoma by describing current practice as starting point develop consensus guidelines. Materials methods An international expert panel treatment comprising 24 (pediatric) radiation oncologists, brachytherapists surgeons met for a Brachytherapy Workshop hosted European paediatric Soft tissue Sarcoma Study Group (EpSSG). panel's clinical experience, results previously...
Object Complete ependymoma resection ensures a better prognosis for children with this tumor, but the complete excision of infratentorial ependymomas involves serious risks. Second-look surgery tumor remnants may be less harmful and enable removal. There is potential, although still unclear, role neoadjuvant chemotherapy in preparation further surgery. Methods Since 1994, authors have adopted two successive protocols intracranial ependymoma, both including phase adjuvant surgical plan...
Rectal toxicity presents a significant limiting factor in prostate radiotherapy regimens. This study evaluated the safety and efficacy of an implantable biodegradable balloon specifically designed to protect rectal tissue during by increasing prostate–rectum interspace. Balloons were transperineally implanted, under transrectal ultrasound guidance, into interspace 27 patients with localized cancer scheduled undergo radiotherapy. Patients underwent two simulations for planning--the first...
CWS/RMS-96 was an international multicenter trial with randomization between two therapy arms of the standard four-drug (vincristine, ifosfamide, adriamycin, dactinomycin [VAIA]) versus intensified six-drug regimen (carboplatin, epirubicin, vincristine, dactinomycin, and etoposide [CEVAIE]) for high-risk rhabdomyosarcoma (RMS), extraskeletal Ewing sarcoma (EES), undifferentiated (UDS) in children, adolescents, young adults aiming to improve their survival. Intensified chemotherapy CEVAIE did...
Abstract Background Myoepithelial carcinoma (MC) of soft tissues is an aggressive tumor that rarely affects children, for whom no established treatment protocols exist. As part the TREP (Tumori Rari in Età Pediatrica) project – Italian network dedicated to children and adolescents with very rare tumors we present a series patients MC, who were treated homogeneously achieved satisfactory outcome. Procedure From 2005 2012, seven (age 0.5–9.2 years) diagnosis MC registered study. After one...